Form 4: Passage Bio Executive Acquires Stock Options
SEC Form 4 Filing
Edgar B. Cale, GC & Corporate Secretary of Passage Bio, Inc., reports the acquisition of employee stock options.
Summary
- On September 30, 2024, Edgar B. Cale, the GC & Corporate Secretary of Passage Bio, Inc., acquired 50,000 employee stock options.
- The exercise price of these options is $0.70.
- The options vest monthly, starting September 1, 2024, over a period of 48 months, contingent upon continued service to the company.
- The expiration date for these options is September 30, 2034.
- Following the transaction, Cale directly owns 50,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Positives
- The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's securities. It provides transparency into executive compensation and ownership.
Stakeholder Impact
- The acquisition of stock options by an executive could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| September 1, 2024 | Vesting of stock options begins. |
| September 30, 2024 | Date of transaction: Edgar B. Cale acquired stock options. |
| September 30, 2034 | Expiration date of the stock options. |
| October 02, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.